Avegant
Developing next-generation display technology to enable previously impossible consumer augmented reality experiences
30 employees · est. 2012 · San Mateo, United States
SanegeneBio
Sanegene Bio is committed to advancing transformative RNAi therapies that address global unmet medical needs.
28 employees · est. 2021 · Woburn, United States
Avegant is the older company (2012 vs 2021).
Side-by-Side Comparison
| Metric | Avegant | SanegeneBio |
|---|---|---|
| Founded | ||
| Founded | 2012 older | 2021 |
| Headquarters | ||
| Headquarters | San Mateo, United States | Woburn, United States |
| Employees | ||
| Employees | 30 | 28 |
| Industry | ||
| Industry | Consumer Electronics, Manufacturing, VR/AR | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series B |
| Total Funding | ||
| Total Funding | $72.74M | $190.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 2 |
| Services | ||
| Services | Not tracked yet | Drug Discovery and Development, Therapeutic Pipeline Management, RNAi Medicines, Targeted Delivery Platform |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Metabolic Disorders, Individuals with Autoimmune Diseases, Healthcare Providers treating Cardiovascular Diseases, Biotech and Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | Augmented Reality, Display Technology, Innovation, Hardware, Venture-backed, Technology Company, Consumer Experiences, Award-winning, Team Collaboration | RNAi Therapies, Genetic Medicines, Obesity Treatment, Cardiometabolic Diseases, Autoimmune Diseases, Drug Discovery, LEAD Technology, Tissue-specific Gene Silencing, Subcutaneous Dosing, RNA Interference, Metabolic Diseases, Cardiovascular Diseases, Immunology |
| Website | ||
| Website | avegant.com | sanegenebio.com |
About Avegant
Avegant is a well-funded, venture-backed technology company founded in 2012, headquartered in the United States, and focused on developing next-generation display technology to enable previously impossible consumer augmented reality experiences. The company's slogan emphasizes its commitment to pion...
About SanegeneBio
Sanegene Bio, a clinical-stage biotechnology company, is committed to advancing transformative RNAi therapies that address global unmet medical needs. Founded in 2021 by industry veterans with deep expertise in RNA interference, Sanegene Bio leverages its proprietary LEAD™ platform to enable tissue-...
We will tell you when either one moves
BounceWatch watches Avegant and SanegeneBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Avegant and SanegeneBio — by email.
Frequently Asked Questions
Compare Avegant with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Avegant on 12 Sep 2024, and SanegeneBio on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.